David J. Moss

Insider Reports History

Reporting-owner location: Tyler, TX
Latest reporting-owner signature: /s/ David J Moss
Source: Latest parsed Forms 3/4/5 signature
Transaction source note: Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for David J. Moss

Form 4 holding Chief Executive Officer, Director

Inmune Bio, Inc.

Security class: Common Stock
Shares / value: 1,294,883
Estimated value: $1,463,217
Report date: 02 Jul 2026
Price: $1.13
Ownership: Direct

Form 4 holding Chief Executive Officer, Director

Inmune Bio, Inc.

Security class: Option (right to buy)
Shares / value: 750,000
Estimated value
Report date: 01 Dec 2025
Price
Ownership: Direct
Underlying class: Common Stock
Underlying amount

Form 4 holding Chief Executive Officer, Director

Inmune Bio, Inc.

Security class: Stock Option (right to buy)
Shares / value: 160,000
Estimated value
Report date: 18 Nov 2025
Price
Ownership: Direct
Underlying class: Common Stock
Underlying amount

Form 4 holding Chief Executive Officer, Director

Inmune Bio, Inc.

Security class: Common Stock Purchase Warrant
Shares / value: 9,014
Estimated value
Report date: 02 Jul 2026
Price
Ownership: Direct
Underlying class: Common Stock
Underlying amount

Insider Reports Filed by David J. Moss

4 INMB

Inmune Bio, Inc.

Report period: 02 Jul 2026
Transactions: 2
Transaction value: $0
Accepted by SEC: 07 Jul 2026, 07:00
Role: Chief Executive Officer, Director
Next action: Open filing details

4 INMB

Inmune Bio, Inc.

Report period: 01 Dec 2025
Transactions: 1
Transaction value: $0
Accepted by SEC: 02 Dec 2025, 16:44
Role: Chief Executive Officer, Director
Next action: Open filing details

4 INMB

Inmune Bio, Inc.

Report period: 18 Nov 2025
Transactions: 16
Transaction value: $0
Accepted by SEC: 18 Nov 2025, 17:31
Role: Chief Executive Officer, Director
Next action: Open filing details

4 INMB

Inmune Bio, Inc.

Report period: 05 Dec 2024
Transactions: 1
Transaction value: $0
Accepted by SEC: 09 Dec 2024, 16:00
Role: Chief Financial Officer, 10%+ Owner
Next action: Open filing details

4 INMB

Inmune Bio, Inc.

Report period: 30 Sep 2024
Transactions: 1
Transaction value: +$52,868
Accepted by SEC: 30 Sep 2024, 16:01
Role: Chief Financial Officer, 10%+ Owner
Next action: Open filing details

4 INMB

Inmune Bio, Inc.

Report period: 12 Sep 2024
Transactions: 2
Transaction value: +$49,985
Accepted by SEC: 16 Sep 2024, 20:47
Role: Chief Financial Officer, 10%+ Owner
Next action: Open filing details

4 INMB

Inmune Bio, Inc.

Report period: 14 May 2024
Transactions: 1
Transaction value: $0
Accepted by SEC: 16 May 2024, 16:09
Role: Chief Financial Officer, 10%+ Owner
Next action: Open filing details

4/A INMB

Inmune Bio, Inc.

Report period: 19 Apr 2024
Transactions: 2
Transaction value: +$152,246
Accepted by SEC: 24 Apr 2024, 14:10
Role: CFO, Treasurer & Secretary, 10%+ Owner
Next action: Open filing details

4 INMB

Inmune Bio, Inc.

Report period: 19 Apr 2024
Transactions: 2
Transaction value: +$152,246
Accepted by SEC: 23 Apr 2024, 17:54
Role: CFO, Treasurer & Secretary, 10%+ Owner
Next action: Open filing details

4 INMB

Inmune Bio, Inc.

Report period: 17 Mar 2023
Transactions: 1
Transaction value: +$16,062
Accepted by SEC: 20 Mar 2023, 08:02
Role: CFO, Treasurer & Secretary, 10%+ Owner
Next action: Open filing details

4 INMB

Inmune Bio, Inc.

Report period: 16 Feb 2023
Transactions: 1
Transaction value: $0
Accepted by SEC: 21 Feb 2023, 15:06
Role: CFO, Treasurer & Secretary, 10%+ Owner
Next action: Open filing details

4 INMB

Inmune Bio, Inc.

Report period: 26 May 2022
Transactions: 2
Transaction value: +$68,649
Accepted by SEC: 31 May 2022, 06:08
Role: CFO, Treasurer & Secretary, 10%+ Owner
Next action: Open filing details

4 INMB

Inmune Bio, Inc.

Report period: 21 Mar 2022
Transactions: 2
Transaction value: +$149,995
Accepted by SEC: 23 Mar 2022, 16:30
Role: CFO, Treasurer & Secretary, 10%+ Owner
Next action: Open filing details

4 INMB

Inmune Bio, Inc.

Report period: 03 Nov 2021
Transactions: 1
Transaction value: -$20,500
Accepted by SEC: 04 Nov 2021, 16:00
Role: CFO, Treasurer & Secretary, 10%+ Owner
Next action: Open filing details

4 INMB

Inmune Bio, Inc.

Report period: 27 Oct 2021
Transactions: 1
Transaction value: -$41,580
Accepted by SEC: 29 Oct 2021, 16:01
Role: CFO, Treasurer & Secretary, 10%+ Owner
Next action: Open filing details

4 INMB

Inmune Bio, Inc.

Report period: 22 Oct 2021
Transactions: 2
Transaction value: -$23,100
Accepted by SEC: 26 Oct 2021, 16:31
Role: CFO, Treasurer & Secretary, 10%+ Owner
Next action: Open filing details

4 INMB

Inmune Bio, Inc.

Report period: 16 Jul 2021
Transactions: 2
Transaction value: +$97,750
Accepted by SEC: 19 Jul 2021, 19:39
Role: CFO, Treasurer & Secretary, 10%+ Owner
Next action: Open filing details

4 INMB

Inmune Bio, Inc.

Report period: 07 Jul 2021
Transactions: 2
Transaction value: -$501,523
Accepted by SEC: 09 Jul 2021, 16:06
Role: CFO, Treasurer & Secretary
Next action: Open filing details

4 INMB

Inmune Bio, Inc.

Report period: 22 Jun 2021
Transactions: 1
Transaction value: $0
Accepted by SEC: 24 Jun 2021, 17:55
Role: CFO, Treasurer & Secretary, 10%+ Owner
Next action: Open filing details

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .